Opioid use disorder (OUD) is a major public health issue in the United States. Medications for OUD, which combines the use of approved medications with counseling and behavioral therapies, represents an evidence-based approach to treat individuals living with an OUD. One approach is injectable naltrexone, an approved and effective treatment, provided by pharmacists, who are more geographically accessible and have legal authority to administer it in some states.
We interviewed community pharmacists and medical providers who prescribe injectable naltrexone, including physicians, physician assistants, and nurse practitioners, to elicit information about marketing pharmacist-provided injectable naltrexone for opioid use disorder. The following naltrexone brochure was developed by the Ford Research Group based on feedback from these providers in the community. To see clips from the interviews please go HERE.
The naltrexone brochure is available to any community pharmacist as a tool for marketing their injectable naltrexone service to providers and clinics.
The naltrexone brochure is available as a download for your pharmacy to use. To access the brochure please follow these instructions:
*The purpose of collecting your name and email address is for download tracking purposes only. If you have any questions, please feel free to contact us HERE.